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When an animal is reexposed  to an antigen a given time after the first contact, it 
produces a secondary response.  The final number of antibody-forming cells engaged 
in the secondary response is 100-1S0 times higher than in the primary (1). This dif- 
ference cannot be explained on the basis of two types of cells involved, higher amount 
of antibody produced per cell, or higher cell division  rate (2, 3). It follows that the 
number of cells which  the antigen can trigger to initiate the characteristic division- 
differentiation-synthesis process increases drastically after primary immunization. 
In this paper immunological memory is  defined as  the persistence of these 
cells at high level for periods up to the life span of the animal. Two basic mech- 
anisms could account for it:  (a) the presence of a  cell line along which the in- 
formation for initiating a  specific response upon challenge is  transmitted  from 
mother to daughter cells, or (b) the recruitment of cells previously not respon- 
sive; this process could be mediated either by the antigen or by some other 
type of informational molecule. Some difficulties of assessing the importance of 
these mechanisms in the intact animal have been circumvented by developing 
a system, described in the first paper of this series (4), which permits measure- 
ment of immunological memory in isolated, adoptively transferred cell popula- 
tions. Since the antigen used (human serum albumin) is not immunogenic for 
the mouse, when in soluble form, the interference of the recipient's own immune 
capacity is  avoided,  and  the  system provides a  means of distinguishing  the 
linear  transmission  from the  recruitment  mechanisms.  In  this  paper  several 
parameters--e.g,  cell  dose,  time,  antigen  dose,  and  irradiation  effect-- are 
studied, and a profile of the decay of immunological memory is presented. 
Materials  and Methods 
Mice.--A.SW/KL  and (/% X  CBA)FI animals were used throughout the  experiments, in 
syngeneic donor-recipient combination. In each experiment mice of the same sex were used. 
Donors were immunized at. 3 months of age and killed 1-6 months later. Recipients were 2-4 
months old at the time of the transfer. 
Irradia:lion Conditions.--A Siemens X-ray machine was used, under the following condi- 
tions: 190 Kv peak, 15 ma; filtration: inherent, 1.5 mm A1; added, 1.0 mm AI -k 0.S mm Cu. 
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The dose rate,  at 50 cm from the source, was about 100 R/min. The standard dose delivered 
to prospective recipients was 500 R. 
Spleen Cell Transfer and Antigen.--These procedures have been described in detail in the 
first paper in this series (4). 
Serology.--Anti-human serum albumin  (HSA) antibodies were titrated by the Farr tech- 
nique, with the procedure described earlier (4). The calculations of antigen-binding capacity 
(ABC) of an antiserum,  expressed in micrograms of HSA bound per milliliter of undiluted 
serum, was done by extrapolating, from the serum concentration capable of binding a certain 
fraction  (between 10 and 75%) of the lalI-labeled human serum albumin present  in the test 
tube, the concentration, expressed as log microliters per milliliter, which would bind 50% of 
the antigen. This extrapolation a was obtained  by the formula 
a  =  log  c  --  0.75 log [fb/(1  -- fb)] 
where v is the serum concentration used, expressed in microliters per milliliter, and fb the frac- 
tion of aibumln bound. The constant 0.75 was determined with a final antigen  concentration 
of 0.5 #g/ml in the reaction mixture. The log ABC of the undiluted serum was then calculated 
by subtracting  the value a from the constant 2.698. Since these calculations, however simple, 
are time-consuming, they are conveniently performed by computer, together  with the statis- 
tical treatment of the data. 
RESULTS 
The Relation between Transferred Cell Number  and Antibody  Produced.--In 
order to define the conditions of the present system, groups of irradiated mice 
were given 2  X  10el 6  )<  106, or 2  ×  107 spleen ceils from the same donor pool, 
and were challenged immediately with 100 #g fluid HSA. The determination of 
the  ABC of their  serum  was  done  10,  201  and  30  days  after  challenge.  The 
results of several experiments are shown in Fig. 1, where the 10 day titer (ABC) 
is plotted  against  the number of transferred  cells  on a  log/log scale.  The  log 
titer increases linearly with the increase of the log of the cell number. The slope 
is about 1.8. A log/log regression with a slope greater than 1 corresponds to an 
accelerating curve in arithmetical scale. In this case, by increasing  10-fold the 
number of cells  transferred,  the  titer  rises  60-fold. A  systematic study of the 
phenomenon,  which is  considered here  as a  "premium" activity of the larger 
inoculal reveals that the only condition where the premium is not found is when 
spleen cells are transferred  to nonirradlatedl  1 month old recipients  (Fig.  1), a 
situation  where  the  expansion  of transferred  cells  is  depressed  (4).  A  certain 
number  of  the  transferred  cells  might  be  diverted  from  potential  antibody 
formation to the fulfillment of the physiological functions necessary to keep a 
severely irradiated mouse alive (5), a phenomenon which would affect the smal- 
lest inocula more severely. This possibility was tested by mixing immune and 
nonimmune cells in various proportions while keeping the total number of in- 
jected cells constant. The results,  also included in Fig. 1, show that this opera- 
tion did not influence the premium. 
The "Premium Effect" in Relation to Antigen Dose and Time of Assay.--The 
observed picture would be easily explained  if optimal stimulation occurred at FRANCO CELADA  201 
different antigen doses for different cell numbers.  This possibility was tested 
by performing two experiments. The first one consisted in giving the chanenge 
in vitro, incubating the donor spleen cell pool with HSA (3 X  1@ cells and 100 
micrograms of HSA per milliliter)  for 1 hr at 37°C,  washing once, diluting to 
the desired concentration, and injecting different cell doses into irradiated  re- 
cipients. The results were not different from the previous ones (Fig. 1). 
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FIG.  1.  Efficiency  of adoptive antibody production relative to the number of transferred 
spleen cells. Log ABC 10 days after challenge is plotted against cell number on a logarithmic 
scale. In vivo challenge, A; in vitro challenge, ©; cell number kept constant by mixing im- 
mune and "normal"  ceils (two separate experiments), D; cells transferred to 1 month old, 
nonirradiated recipients, A. Eight to 10 animals per group. The broken line, given for refer- 
ence, has a theoretical slope of 1. 
The second experiment consisted in a  complete mapping of cell and antigen 
doses. Each inoculum of 2 X  106, 6 X  10% and 2 X  107 immune cells was given 
to eight groups of recipients, and each antigen dose of a  series ranging in  10- 
fold steps from 10  -q to 103 #g was administered to three  groups of mice that 
had received the three doses of cells. The results of this experiment are shown 
in Fig. 2, where the peak titers, expressed as log ABC, are plotted against the 
dose of challenging HSA for each cell dose. The resulting curves are roughly 
parallel for most of their span; in agreement with M~tkelii and Mitchison  (6), 
10  -3 #g is the minimum dose that elicits a  secondary response detectable over 202  ADOPTIVE IMMUNOLOGICAL  MEMORY IN MICE 
the residual primary titer produced in the absence of challenge.  The substan- 
tial  increase  in  antibody  formed  takes  place  between  10  --~  and  1  #g  chal- 
lenge,  with  a  rate  approaching proportionality between  antigen  injected  and 
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FIo. 2. Profile of secondary immune response of three cell numbers, relative to the dose of 
challenging antigen.  Log ABC at peak level is plotted  against log micrograms  of HSA in- 
jected into the recipients after transfer. 2 ×  10  ~  transferred spleen ceils, O; 6 X  106, O; 2 X 
106, @. Each point represents the mean of 8-10 animals. Vertical bars indicate the 95% con- 
fidence limits. 
antibody synthesized.  A  plateau,  indicating optimal stimulation  of the trans- 
ferred cells, is reached between  10 and  100 #g; by further increasing the chal- 
lenge dose to 1000 #g, the effect on the three transfer cell doses is a  depression 
of the plateau level. This paralysis effect on primed cells is particularly marked 
on the highest cell dose, where the actual antibody produced is less than 20 % FRANCO  CELADA  203 
of the amount produced  upon optimal stimulation, while the activity of the 
smallest cell dose is almost unaffected. 
The distance between the highest and the lowest curve in Fig. 2 is, with the 
exception of the points corresponding to 10  -4 and to 103 #g challenge, always 
greater than 1 log unit on the ordinate. Since the two extreme cell doses con- 
sidered here are 10-fold apart, this observation points out the consistency of 
the "premium effect" over the entire range of antigen doses used  to elicit a 
secondary response, provided there is no antigen-induced  paralysis. 
TABLE  I 
Effect of Antigen  Dose and Bleeding Time on tke Effwiency of Antibody  Production (ALog 
ABC/A£og Number of Cells Transferred) 
Challenge 
dose of 
HSA/ 
mouse 
~g 
0.0001 
0.~1 
0.01 
0.1 
1.0 
10.0 
1~.0 
1000.0 
10-day 
slope 
1.~¢ 
1.Tw~ 
1.Tr'/ 
2.0C~ 
1.062 
S 
0.209 
O.  129 
0.109 
O.  169 
0.279 
OAf6 
O.  153 
O.  167 
df 
17 
20 
19 
20 
18 
18 
20 
17 
p* 
:0.10 
:0.05 
:0.001 
:0.001 
:0.20 
:0.001 
:0.005 
0.60 
20-day 
slope 
1.199 
1.199 
1.r~i9 
2.~6~t 
1.599~t 
0.$11~t 
S 
O. 139 
0.130 
0.078 
0.122 
0.174 
O. 283 
0.492 
0.179 
<C  !0 
<C  t0 
<C  }01 
<C  }01 
<C  )05 
<C  !0 
<C  )2 
0-day 
slope  S 
0.$99  0.185 
0.8~I  O.  109 
lf~16  0.134 
1.957  O. 148 
1.§17  0.182 
1.291  O. 210 
1.067  0.090 
O.H2  0.181 
~f  P 
16  -- 
19  -- 
18  <0.001 
17  <0.001 
14  <0.01 
13  <0.20 
15  0.50 
13  -- 
For each challenge dose the slopes were  calculated from the regression lines fitted to  10-, 20-,  and 30-day 
titers for 3  or 4 cell doses.  For each  slope the  standard  deviation (S),  the degrees of freedom  (dr),  and  the 
probability  level  (P)  are listed. Intercepts are omitted. 
* Hypothesis tested: experimental slope ffi 1. Calculation: (slope -- 1)IS =  t. The result was compared with 
the t values for the corresponding degrees of freedom. The table  used  lists  the following P  values: 0.20,  0.10, 
0.05, 0.025, 0.02, 0.01, 0.005, 0.001. 
Peak titer is reached at this  bleeding. 
Antigen dose has also an effect on the time interval between challenge and 
attainment of antibody peak level. The peak is near the first bleeding (10 days) 
with a  challenge of 0.001 and 0.1/zg HSA, while it is at the second bleeding 
(20 days) with higher antigen doses. Table I shows in greater detail the time 
relationship among challenge, antibody peak,  and relative efficiency per cell 
(in terms of titer/cell dose slope) for each antigen dose. The slope is greater 
than 1 in practically every instance, although there is a tendency of the "pre- 
mium" to decrease after peak titer has been reached.  The greatest premium 
(200-fold increase of antibody for 10-fold cell number)  is found 20 days after 
the suboptimal challenge dose of 0.1/zg HSA. 
The  Secondary  Response  after  Immediate  or Delayed  Challenge.--A  series of 
experiments was performed to answer the following questions:  (a) What is the 
magnitude of the secondary response  of transferred cells challenged  after a 
long sojourn in the syngeneic recipient,  relative to that produced immediately 204  ADOPTIVE IMMUNOLOGICAL  MEMORY  IN MICE 
after transfer? (b) Do preirradiation of the recipients and inoculum size affect 
the kinetics of memory? 
Immune spleen cells from the same donor  pool were transferred to several groups of recipients, 
either exposed to 500 R or nonirradiated. The challenge (10 or 100 #g HSA intraperitoneally) 
was given to one group immediately after transfer, and to the other ones at different time in- 
tervals, e.g. 1 or 2 months or longer. The antibody titers in the serum of the recipients were 
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FIG. 3.  Kinetics of the adoptive secondary response elicited immediately, 28,  or 78 days 
after spleen cell transfer. Log ABC is plotted against time after transfer. 2 X  107 cells trans- 
ferred,  © andO; 6 ×  106, •  and I. Circles show titers produced after challenge with 10 #g 
HSA. Squares show titers produced without challenge  ("residual primary response"). Each 
point is the mean of 8-I0 animals. 
followed from the day of transfer (for the groups receiving immediate challenge and for groups 
not challenged at aU) or from the day of challenge (for the other groups). 
One of these experiments, where two cell doses were transferred, is shown in 
Fig. 3. It has the following features: (a) Nonchallenged groups show an anti- 
body titer which increases to reach a  peak at about day 20 and then declines 
steadily. This titer, termed here "residual primary response," is directly pro- 
portional to the number of cells transferred. (b) The groups receiving the antigen 
immediately after transfer have the highest antibody titer, the time and shape 
of the peak being very similar to those of nonchallenged recipients, at a  higher FP.ANCO CELADA  205 
level. In Fig. 3  this level is about 60 times greater than the residual primary 
response. In other experiments, a  lower residual primary response was usually 
observed, and the secondary response had a gain factor of about 100. The peak 
titer in recipients to which different cell doses were transferred shows the phe- 
nomenon of "premium" at the higher dose. This is true also for delayed chal- 
lenges.  (c)  The  antibody  peaks  in  recipients  challenged  at  intervals  after 
receiving the transfer grow  lower with  the increase of the interval between 
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FIG. 4. Biphasic decline of immunological  memory. The peak titer reached upon delayed 
challenge  relative to titer reached upon immediate  stimulation is plotted on a semilogarithmic 
scale. On the abscissa: time of challenge  after cell transfer. Each point represents the mean of 
5-10 mice.  Vertical  bars indicate the 95% confidence  limits. The same  key is used for data from 
the same transfer experiment. 
transfer and challenge. The difference between challenge at time 0  and chal- 
lenge at  1-2 months is greater than between 1 month and 3-4 months.  This 
picture is true for all cell doses tested (Fig. 3) and also for 'the case when the 
spleen cells are transferred into nonirradiated young recipients, although their 
antibody-forming efficiency is lower, as has been described (4). (d) Recipients 
of spleen cells from donor mice either nontreated or treated only with Freund's 
adjuvant did not produce any antibody in response to the challenge. 
The Measure of the Decline of Memory.--A profile of the immunological mem- 
ory of the primed cells over several months is obtained by connecting the mean 
peak titers reached when the same number of cells from the same donor pool is 
challenged immediately vs. at given intervals after transfer. Data from several 
experiments, including those illustrated in Fig. 3, are combined in Fig. 4. With- 206  ADOPTIVE  IMMUNOLOGICAL  MEMORY  IN  MICE 
in each experiment the peak titers after delayed stimulation are expressed rel- 
ative to the peak titer following the time 0 challenge, taken as  1.0.  The profile 
shows a biphasic decline. The half-life of the hand-fitted slopes is 15 days during 
the first 40 days, and about 100 days during the following 3 months. To express 
the memory as  the number of antigen-responsive cells  present  at any given 
time, it is necessary to correct for the nonproportionality of cell number and 
antibody titer. This is done by solving for x  the equation y  =  1.8  x,  which 
describes the relative titer (y) as a function of cell number (x). 1.8 is the mean 
slope determined experimentally. Mter correction, the two phases of decline of 
the potentially responding cell population have half-lives of 26 days and  190 
days, respectively. There is a similarity between the decay curve of the memory 
and that of serum titers after the peak of a secondary or of a "residual" primary 
response is  reached; this  is  evident if one compares Figs.  3  and 4.  However, 
while  the first  curve is  a  direct measure of the secondary antibody-forming 
TABLE II 
Decline of Potential Immune Capacity of Normal  and Irradiated  Tram 
Day of challenge 
after transfer 
0 
30 
80 
Control peak titer 
(log ABC)* 
2.11  -4- 0.21 
1.35  ±  0.30 
0.99 ±  0.44 
150 R  peak titer 
(log ABC)* 
1.48  4- 0.30 
0.80 ±  0.14 
0.60 ±  0.16 
(150 R ABC/ 
control ABC) 
X  100 
23 
29.5 
40 
(Control ABC/ 
control, time O) 
X  I00 
100 
17 
7.7 
Fer Cdls 
(150 R  ABC/150 
R, time 0)  X  100 
100 
21 
13 
* Mean +  95% confidence limits. 
potential of the transferred population, the second one is more complex, result- 
ing from continued production, accumulation, and natural decay rate of the 
antibody. 
The  Tertiary  Response.--A  tertiary response was elicited by injecting mice, 
which had already been challenged at the time of transfer, with another stand- 
ard dose of HSA. The results of these experiments showed that (a) when the 
tertiary stimulation was given during the first month after the secondary, no 
significant  increase  of  the  circulating antibody was  obtained;  (b)  when  the 
interval between the two challenges was 2--4 months there was a  consistently 
significant rise in titer over the residual secondary titer, although (e) the peak 
of the tertiary response was not significantly different from that of the secondary 
response elicited at the same time, in a group that had received a transfer from 
the same cell pool, but had not been challenged at time 0. 
The Radiosensitivity  of Memory.--The  radiosensitivity of memory was tested 
in the present system by studying (a) the effect of irradiation to the spleen cells, 
at the time of transfer, on their ability to build up an  immediate vs.  delayed 
secondary response, and (b) the effect of irradiation at the time of challenge of 
cells cultured for short vs. long periods in the recipients. FP.ANCO CELADA  207 
The first experiment was performed by exposing the donor cell suspension in vitro to  150 
R prior to transfer into irradiated redpients; these,  in separate groups,  were challenged  on 
days 0, 30, and 80 after transfer. Control groups received nonirradiated cells and were chal- 
lenged at the same times. 150 R was chosen as the dose suppressing about 800/0 of the func- 
tional cells, according to preliminary experiments in this system, as well as in other transfer 
systems utilizing immediate secondary challenge. 
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FIG. 5.  Relative antibody production by transferred spleen cells when irradiated in the 
recipient, at the time of challenge. The residual titer is plotted against the radiation dose in 
R, on a semilog scale, the titer in the absence of irradiation being equal to 1. Transfer on the 
same day of irradiation and challenge,  O; transfer 30 days before irradiation and challenge, 
0. Each point represents the mean of 6-10 mice. Vertical bars indicate the 95% confidence 
limits. 
The results are summarized in Table II, where the peak titers produced by 
irradiated and nontreated cells are given for each challenge time, as mean ABC 
±  95 %  confidence intervals. The columns with the relative values essentially 
show  that  exposure  to  X-rays  destroyed a  fraction  of  the  antibody-forming 
potential of the transferred cells, and that the decline of memory of irradiated 
and control cells is roughly parallel thereafter. There is no statistically signifi- 
cant evidence of long-term repair of the damage or any delayed manifestation 
of it. 
A second  experiment  was designed  to compare the effect of radiation on the "memory 
cells" at the time of challenge. Two series of groups of recipients were exposed to 0, 150, 300, 208  ADOPTIVE IMMUNOLOGICAl,  MEMORY IN MICE 
and 400 R X-rays. To one of the two series, donor cells had been transferred 1 hr previously~ 
while the other had received a  ~rnilar transfer 30 days earlier. 
In Fig. 5 the results are expressed in terms of surviving activity at any given 
dose, relative to the activity (peak antibody titer) at 0 R. The picture reflects 
a complex phenomenon, since radiation given under these conditions has two 
potential effects: It kills part of the competent cells,  but at the same time it 
enhances the activity of the survivors, as it destroys the so-called barrier to 
syngeneic transplantation (4), presumably by producing more space for popu- 
lation expansion. The resultant of these opposite effects can be predicted from 
the inactivation curves for antibody-forming cells  (7)  and for the  "barrier" 
(4). As expected, the inactivation is less efficient than when spleen cells are ir- 
radiated prior to transfer; there is a considerable shoulder, and, in the case of 
the recently transferred cells, a tendency to overshoot, relatively to the nonir- 
radiated controls  (Fig.  5).  Comparison of the  two curves falls to  show any 
significant difference in radiosensifivity between the freshly transferred and the 
in vivo cultured cell populations. 
DISCUSSION 
Four points are relevant for the interpretation of the present results,  and 
should be discussed: (a) the accuracy of quantitation of the immune response, 
(b) the assumption that there is no recruitment of host  cells in the adoptive 
immunity anti-liSA, (c)  the possible cytokinetic model based on the memory 
decay picture,  and  (d)  the  significance of  adoptive immunological memory 
for the anamnestic capacity of the intact animal. 
We find that the serum titer of anti-HSA is not proportional to the number 
of immune cells transferred to an irradiated mouse: the increase in log titer 
(antlgen-binding capacity titers are distributed log-normally) is ~-~1.8 for 1 log 
unit increase in cell number. This constant finding, although it does not prevent 
extrapolation from antibody in the circulation to active cells in the animal, is 
certainly unexpected.  Proportionality was  found  by  Makinodan  et  al.  (8), 
working with particulate antigens--with  the exception of the very early re- 
sponse--and by M~ikel~ and Mitchison with soluble protein antigens (9).  The 
contradiction between the latter report and the present one might be only ap- 
parent, since we used a lower range of cell doses: higher inocula saturate  the 
system, thereby depressing the efficiency of antibody production per cell  (1). 
The mechanism of the "premium" phenomenon remains unexplained, after 
antigen concentration,  absolute  number  of cells  transferred,  and  time after 
challenge are excluded as possible causes. We are forced to postulate some sort 
of collaboration among antibody-forming cells; their physical vicinity in  the 
case of high inocula would increase the probability of interaction. This in turn 
would enhance either cell division, rate of synthesis, and/or utilization of anti- 
gen. Along this line of reasoning one can imagine the formation of structures 
similar to germinal centers to be necessary for adoptive antibody formation. ~'RANCO CELADA  209 
Preliminary experiments indicate that anti-HSA response by small cell trans- 
fers is enhanced by the presence of syngeneic cells  reacting to an unrelated 
antigen (Celada, unpublished data). This suggests a  nonspecific collaboration. 
Another possibility, which is presently being checked in our laboratory, is that 
the quality of the antibodies produced by a big cell inoculum differs from that 
produced by a small one, e.g., in antigen-binding efficiency. 
There  is  considerable evidence that  the  adoptive response  in  the  present 
system is due solely to the activity of the donor ceils and their descendants: (a) 
No antibodies are found when the standard challenge dose of HSA is injected 
into a normal mouse or a mouse to which nonimmune syngeneic cells have been 
transferred. (b)  The potential antibody-forming capacity of the transfer ceils 
is highly radiosensitive, since protein and RNA synthesis as well as antigen 
disposal by phagocytes are more radioresistant (10,  11). This finding suggests 
that mitosis is an essential step in the adoptive response. (c) Exposure of pros- 
pective recipients to X-ray doses which are known to  reduce  drastically the 
lymphoid cell number results in an enhanced adoptive response (4).  The op- 
posite effect would be obtained if the recipient's own cells played any important 
part in it. The decline of memory, in the absence of seft-renewal, also speaks 
against horizontal transmission of information from the donor to the recipient. 
We interpret it as a slow dying off (or diverging) of the competent cell line, with 
a considerably long haft-life (6 months, in the second phase). Our observation 
time, when the age of the donors is also taken into account, is too short to 
identify the memory decay with a recently studied phenomenon, the senescence 
of the immune system (12). 
The  mechanism responsible  for a  linear  transmission  of memory  could be 
genetic or cytoplasmic: For instance, a "unit" of antigen could be passed along 
from mother to daughter cell. The present data do not allow a discrimination 
at this level, although recent experiments in this laboratory have demonstrated 
that the haft-life of HSA as an immunogen is on the order of 1 day in normal 
mice.  x  The cytokinetics leading to the ananmestic response can also be visualized 
in two alternative ways, which can be tested experimentally. 
The One Cell Line Hypothesis  (A).--Memory cells and actual antibody pro- 
ducers comprise the same cell population. Its expansion is triggered either by 
the antigen or by nonspecific stimuli, and is limited by the number of mitoses 
a cell can undergo. The antigen acts also as an inducer of antibody production. 
The expansion of the population of competent donor cells is the same in  the 
presence or the absence of antigen, the lethally irradiated recipient providing 
the nonspecific stimulus for cell division. If the antigen is present at time 0, 
antibody production rises and decays with the expansion and slow decay of the 
transferred population. If the antigen is made available only later, the expansion 
of the transfer will not be different, but it will not be reflected in antibody pro- 
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duction; this function will only begin at the time of the injection of antigen 
inducer. At this very moment the cells will begin to produce antibody, without 
having to undergo further mitoses. If the challenge is given when the population 
curve is declining, the titer consequently will be lower than the peak reached 
with a  time 0  challenge. 
The Two Cell Lines Hypothesis  (B).--The adoptive secondary response is the 
result of the activity of two cell lines, one deriving from the other. One, the 
"memory" cells,  are  stem  cells  which  have  been  specifically determined  or 
"selected out" at the time of the first contact with the antigen. They pass on, 
from mother to daughter cell through mitosis, the capacity to give rise to an 
antibody-producing cell line. The characteristic effect of the antigen is to pro- 
duce the second cell line from the "memory" line. Since the memory line is not 
exhausted in  this  process,  this  event may take  place  through  asymmetrical 
mitosis.  The antibody-producing line undergoes rapid mitotic expansion and 
differentiation while producing antibody. These are the well-known features of 
the secondary response (13). The memory cell line sets the starting point for 
the "production line."  Since the latter is assumed to have a  limited number 
of divisions to undergo, it also gives the limit of final antibody peak at  each 
time after the primary stimulation. Thus, the size of the peak titers at different 
intervals after transfer reflects the decline of the memory cells.  There are two 
points which allow discrimination between (A) and (B) : the radiosensitivity of 
the delayed vs. the immediate secondary response [according to (A) no mitosis 
would be necessary in a  delayed response] and the influence of the secondary 
stimulation on the magnitude of the tertiary response. Both experiments are 
described in this paper, and the results are in favor of hypothesis (B). 
The last question is the extent to which the vertical transmission accounts 
for the memory of the intact animal.  The present results show a  remarkable 
stability of the memory: In the intact animal, where only a  part of the anti- 
body-forming capacity is used in a normal secondary response, no decline at all 
would be seen for yearlong periods, when the starting level is supramaximal. A 
recent estimate by Makinodan and Peterson (12)  gives a half-life of 26 weeks 
for the secondary antibody-forming potential against sheep red blood cells in 
the intact mouse. This figure agrees with our estimate of the memory decline. 
SUMMARY 
A calibrated cell transfer system allows detection of the anamnestic response 
to albumin without interference from the host's immune machinery; it was used 
to  study  the  immunological memory of mouse  spleen  cell populations.  The 
secondary antibody-forming capacity of the transferred cells was measured by 
challenging them at periods up to 6 months after transfer. The peak levels at- 
tained show a  declining pattern in two phases: during the first month with a 
half-life of 15 days; thereafter, with a half-life of 100 days. The corresponding 
half-lives of the cellular memory are 26 and  190  days. FRANCO  CELADA  211 
In the light of these  and  of radioinactivation  data,  immunological  memory 
is defined  as the  persistence  of a  specifically determined  stem  cell  line,  along 
which the information necessary to give rise to an antibody-forming cell popu- 
lation is transmitted from mother to daughter  cells. 
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